Clinical trial
Study of GW685698X In Patients With Seasonal Allergic Rhinitis
NCT00363740 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00363740 |
|---|---|
| Title | Study of GW685698X In Patients With Seasonal Allergic Rhinitis |
| Official title | Clinical Evaluation of GW685698 for Seasonal Allergic Rhinitis -A Placebo-controlled Study to Determine the Non-inferiority of GW685698 Over Fluticasone Propionate Using a Double-blind Manner- |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Drug |
| Interventions | GW685698X Aqueous Nasal Spray |
| Enrollment | 38 |
| Start date | Feb 19, 2005 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 13, 2005 |
| First posted | Aug 15, 2006 |
| Last update posted | Aug 31, 2018 |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: